FDA Warning Letter — Dongying Tiandong Pharmaceutical Co Ltd

Case 506849 — FEI 3004395180

The FDA took a Warning Letter action against Dongying Tiandong Pharmaceutical Co Ltd on November 10, 2016 (Dongying, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Dongying Tiandong Pharmaceutical Co Ltd
Date
November 10, 2016
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
Dongying (China)